查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575025

癌症诊断市场中的人工智慧，按疾病类型、成分、最终用户、国家和地区划分 - 2024-2032 年行业分析、市场规模、市场份额和预测

AI in Cancer Diagnostics Market, By Disease Type, By Component, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年，癌症诊断中的人工智慧市场规模为9.0198亿美元，2024年至2032年的复合年增长率为9.40%。

癌症诊断市场中的人工智慧-市场动态

新药组合的不断开发以及对标靶和免疫疗法的需求不断增长预计将推动市场需求

人工智慧（AI）已成为癌症诊断领域的变革力量，显着增强了检测和分类各种类型癌症的能力，促进了市场成长。人工智慧可以分析成像模式，以确定癌症的类型和阶段，以及可能影响治疗选择的其他特征。它还评估组织样本，识别异常细胞并量化肿瘤特征，这对于诊断至关重要。人工智慧演算法可以处理大型基因组资讯资料集，以识别与特定癌症相关的突变，从而有助于个人化医疗。因此，对基因组资料不断增长的需求有助于人工智慧在癌症诊断中的广泛采用。

此外，人工智慧驱动的临床决策支援系统（CDSS）有助于整合患者资料和临床指南，以提出最有效和最新的治疗计划。 NLP 工具可以透过提供相关文献或先前病例摘要来帮助临床医生为治疗决策提供资讯。因此，人工智慧正在彻底改变癌症诊断的格局，实现更早的检测、更准确的诊断和个人化的治疗策略。随着技术和方法的不断进步，肿瘤学家、研究人员和资料科学家之间的合作对于充分发挥人工智慧在肿瘤学领域的潜力至关重要。

癌症诊断市场中的人工智慧 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 9.40% 左右的复合年增长率成长

根据疾病类型细分，由于大量饮酒和吸烟会引发癌症，预计其他细分市场将在 2023 年显示最大的市场份额。

根据组件细分，由于软体解决方案在医疗领域的快速采用，软体细分市场将在 2023 年成为领先的组件细分市场。

根据最终用户细分，由于癌症盛行率不断上升，医院细分市场将在 2023 年成为领先的最终用户细分市场。

从地区来看，由于人工智慧技术在医疗保健产业的采用，北美在 2023 年成为领先的收入来源。

癌症诊断市场中的人工智慧—細項分析：

全球癌症诊断市场中的人工智慧会根据疾病类型、成分、最终用户和地区进行细分。

依疾病类型，市场分为五类：乳癌、肺癌、摄护腺癌、脑肿瘤等。其他细分市场主导市场。烟酒消费的增加主要推动了细分市场的成长。

市场依组件分为三类：软体、硬体和服务。软体部分在市场上占据主导地位。云端系统和物联网支援的人工智慧服务的日益普及正在推动细分市场的需求。

根据最终用户，市场分为三类：医院、外科中心等。医院领域在市场中占据主导地位，预计在预测期内将保持其高度主导地位。医院工作流程和平台中越来越多地采用人工智慧驱动的解决方案，补充了市场的成长。

癌症诊断市场中的人工智慧 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。由于先进的医疗基础设施、强大的研发能力，北美成为最大的区域市场。由于受癌症影响的人口基数庞大且医疗保健投资不断增长，预计亚太地区在预测期内将经历最高的年复合成长率(CAGR)。欧洲是另一个重要市场，其推动因素包括先进人工智慧技术的采用、对研究的高度重视以及癌症的高盛行率。

癌症诊断市场中的人工智慧—竞争格局：

癌症诊断市场中人工智慧 (AI) 的竞争格局是由几家知名公司以及技术进步和战略合作伙伴关係的快速发展所决定的。市场的主要参与者包括成熟的医疗保健技术公司以及专注于专业人工智慧解决方案的创新新创公司。市场参与者正在强调开发能够在早期阶段高精度检测癌症的人工智慧解决方案。这包括 MRI、CT 扫描和数位病理学等影像方式的进步。

2023 年，NVIDIA 与美敦力 (Medtronic) 合作，将 AI 技术整合到美敦力 (Medtronic) 的 GI Genius 智慧内视镜模组中，增强对可能发展为癌症的结直肠息肉的早期检测。

2023年，梅奥诊所和Numares Health扩大了合作，开发基于人工智慧的慢性病诊断测试，这也可以增强癌症诊断能力。

2022 年 3 月，微软收购了环境智慧与对话式 AI 领域的领导者 Nuance Communications。

目录

第 1 章：癌症诊断市场中的人工智慧概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 人工智慧在癌症诊断市场中的疾病类型片段
    • 人工智慧在癌症诊断市场中的组成部分片段
    • 人工智慧在癌症诊断市场的最终用户片段
    • 人工智慧在癌症诊断市场的国家片段
    • 癌症诊断中的人工智慧市场片段（按地区）
  • 竞争洞察

第 3 章：人工智慧在癌症诊断的主要市场趋势

  • 癌症诊断市场驱动因素中的人工智慧
    • 市场驱动因素的影响分析
  • 人工智慧在癌症诊断市场的限制
    • 市场限制影响分析
  • 人工智慧在癌症诊断市场机会
  • 人工智慧在癌症诊断市场的未来趋势

第 4 章：癌症诊断产业中的人工智慧研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：癌症诊断市场中的人工智慧：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：癌症诊断市场格局中的人工智慧

  • 2023 年癌症诊断中的人工智慧市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：癌症诊断市场中的人工智慧 - 按疾病类型

  • 概述
    • 按疾病类型分類的细分市场份额分析
    • 乳癌
    • 肺癌
    • 摄护腺癌
    • 脑肿瘤
    • 其他的

第 8 章：癌症诊断市场中的人工智慧 - 按组成部分

  • 概述
    • 按组成部分分類的细分市场占有率分析
    • 软体
    • 硬体
    • 服务

第 9 章：癌症诊断市场中的人工智慧 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 手术中心
    • 其他的

第 10 章：癌症诊断市场中的人工智慧 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 癌症诊断中的人工智慧北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按疾病类型）
    • 北美市场规模和预测（按组成部分）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲癌症诊断中的人工智慧主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按疾病类型）
    • 欧洲市场规模和预测（按组成部分）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 人工智慧在癌症诊断的应用 亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按疾病类型）
    • 亚太地区市场规模和预测（按组成部分）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲癌症诊断中的人工智慧主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按疾病类型）
    • 拉丁美洲市场规模和预测（按组成部分）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 人工智慧在癌症诊断中的应用中东和非洲的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按疾病类型）
    • 中东和非洲市场规模及预测（按组成部分）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 癌症诊断产业中的人工智慧

  • 竞争仪表板
  • 公司简介
    • EarlySign
    • Cancer Center.ai
    • Microsoft
    • Flatiron
    • Path AI
    • Therapixel
    • Tempus
    • Paige AI, Inc.
    • Maxwell Plus
    • Kheiron Medical Technologies Limited
    • SkinVision
    • Cancer Diagnostics Inc.
    • Siemens Healthineers
    • GE Healthcare
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4018

REPORT HIGHLIGHT

AI in Cancer Diagnostics Market size was valued at USD 901.98 Million in 2023, expanding at a CAGR of 9.40% from 2024 to 2032.

Combination therapy drug treatment refers to the use of two or more medications simultaneously to treat a disease or medical condition. This approach is commonly used in various fields of medicine to enhance treatment efficacy, reduce the risk of resistance, and target multiple aspects of a disease or condition. The drugs used in combination therapies can act through different mechanisms or at different stages of disease progression, providing a synergistic effect that single-drug treatments may not achieve.

AI in Cancer Diagnostics Market- Market Dynamics

Increasing development of new drug combinations and rising demand for targeted & immunotherapies is expected to propel market demand

Artificial Intelligence (AI) has emerged as a transformative force in the field of cancer diagnostics, significantly enhancing the ability to detect and classify various types of cancer, boosting market growth. AI can analyze imaging patterns to determine the type and stage of cancer, as well as other characteristics that may influence treatment options. It also evaluates tissue samples, identifying abnormal cells and quantifying tumor characteristics, which is essential for diagnoses. AI algorithms can process large datasets of genomic information to identify mutations associated with specific cancers, aiding in personalized medicine. Thus, growing demand for genomic data is contributing to high adoption of AI in cancer diagnostics.

Further, AI powered Clinical Decision Support System (CDSS) helps integrate patient data and clinical guidelines to suggest the most effective and up-to-date treatment plans. NLP tools can aid clinicians by providing relevant literature or previous case summaries to inform treatment decisions. Thus, AI is revolutionizing the landscape of cancer diagnostics, enabling earlier detection, more accurate diagnoses, and personalized treatment strategies. As technology and methodologies continue to advance, collaboration among oncologists, researchers, and data scientists will be crucial for harnessing the full potential of AI in oncology.

AI in Cancer Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.40% over the forecast period (2024-2032)

Based on Disease Type segmentation, the others segment was predicted to show maximum market share in the year 2023, owing to high consumption of alcohol & tobacco inviting cancer diseases.

Based on Component segmentation, software segment was the leading Component segment in 2023, due to the rapid adoption of software solution in medical sector.

Based on End User segmentation, hospitals segment was the leading End User segment in 2023, due to increasing prevalence of cancer.

On the basis of region, North America was the leading revenue generator in 2023, due to the adoption of AI technologies in healthcare industry.

AI in Cancer Diagnostics Market- Segmentation Analysis:

Global AI in Cancer Diagnostics Market is segmented on the basis of Disease Type, Component, End User, and Region.

The market is divided into five categories based on Disease Type: breast cancer, lung cancer, prostate cancer, brain tumor, and others. The others segment dominates the market. The increasing consumption of tobacco & alcohol is mainly boosting segment growth.

The market is divided into three categories based on Component: software, hardware, and services. The software segment dominates the market. The increasing adoption of cloud systems and IoT enabled AI services are boosting segment demand.

The market is divided into three categories based on End User: hospitals, surgical centers, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. The rising utilization of AI powered solutions into the workflows & platforms of hospital is supplementing market growth.

AI in Cancer Diagnostics Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is the largest regional market due to advanced healthcare infrastructure, strong research and development capabilities. Asia-Pacific is anticipated to experience the highest compound annual growth rate (CAGR) over the forecast period due to a large cancer-affected population base and growing healthcare investments. Europe is another significant market, driven by the adoption of advanced AI technologies, a strong focus on research, and a high prevalence of cancer.

AI in Cancer Diagnostics Market- Competitive Landscape:

The competitive landscape of Artificial Intelligence (AI) in the cancer diagnostics market is shaped by several prominent companies and the rapid pace of technological advancements and strategic partnerships. Key players in the market include well-established healthcare technology companies as well as innovative startups focusing on specialized AI solutions. Market players are emphasizing developing AI solutions that can detect cancer at an early stage with high precision. This includes advancements in imaging modalities like MRI, CT scans, and digital pathology.

In 2023, NVIDIA and Medtronic collaborated to integrate AI technology in Medtronic's GI Genius intelligent endoscopy module, enhancing early detection of colorectal polyps that could develop into cancer.

In 2023, Mayo Clinic and Numares Health expanded their collaboration to develop AI-based diagnostic tests for chronic diseases, which can also enhance cancer diagnostic capabilities.

In March 2022, Microsoft acquired Nuance Communications, a leader in ambient intelligence and conversational AI.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AI IN CANCER DIAGNOSTICS MARKET KEY PLAYERS

  • EarlySign
  • Cancer Center.ai
  • Microsoft
  • Flatiron
  • Path AI
  • Therapixel
  • Tempus
  • Paige AI, Inc.
  • Maxwell Plus
  • Kheiron Medical Technologies Limited
  • SkinVision
  • Cancer Diagnostics Inc.
  • Siemens Healthineers
  • GE Healthcare
  • Others

GLOBAL AI IN CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Breast cancer
  • Lung cancer
  • Prostate cancer
  • Brain tumor
  • Others

GLOBAL AI IN CANCER DIAGNOSTICS MARKET, BY COMPONENT- MARKET ANALYSIS, 2019-2032

  • Software
  • Hardware
  • Services

GLOBAL AI IN CANCER DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospital
  • Surgical Centers
  • Others

GLOBAL AI IN CANCER DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. AI in Cancer Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. AI in Cancer Diagnostics Market Snippet by Disease Type
    • 2.1.2. AI in Cancer Diagnostics Market Snippet by Component
    • 2.1.3. AI in Cancer Diagnostics Market Snippet by End User
    • 2.1.4. AI in Cancer Diagnostics Market Snippet by Country
    • 2.1.5. AI in Cancer Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. AI in Cancer Diagnostics Key Market Trends

  • 3.1. AI in Cancer Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. AI in Cancer Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. AI in Cancer Diagnostics Market Opportunities
  • 3.4. AI in Cancer Diagnostics Market Future Trends

4. AI in Cancer Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AI in Cancer Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. AI in Cancer Diagnostics Market Landscape

  • 6.1. AI in Cancer Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. AI in Cancer Diagnostics Market - By Disease Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 7.1.2. Breast cancer
    • 7.1.3. Lung cancer
    • 7.1.4. Prostate cancer
    • 7.1.5. Brain tumor
    • 7.1.6. Others

8. AI in Cancer Diagnostics Market - By Component

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 8.1.2. Software
    • 8.1.3. Hardware
    • 8.1.4. Services

9. AI in Cancer Diagnostics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospital
    • 9.1.3. Surgical Centers
    • 9.1.4. Others

10. AI in Cancer Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. AI in Cancer Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. AI in Cancer Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. AI in Cancer Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. AI in Cancer Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. AI in Cancer Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- AI in Cancer Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. EarlySign
    • 11.2.2. Cancer Center.ai
    • 11.2.3. Microsoft
    • 11.2.4. Flatiron
    • 11.2.5. Path AI
    • 11.2.6. Therapixel
    • 11.2.7. Tempus
    • 11.2.8. Paige AI, Inc.
    • 11.2.9. Maxwell Plus
    • 11.2.10. Kheiron Medical Technologies Limited
    • 11.2.11. SkinVision
    • 11.2.12. Cancer Diagnostics Inc.
    • 11.2.13. Siemens Healthineers
    • 11.2.14. GE Healthcare
    • 11.2.15. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us